Semaglutide (Ozempic/Wegovy) in India — Price, Generic Alternatives & Medical Tourism Guide

Semaglutide changed the obesity treatment landscape. Under brand names Ozempic (diabetes) and Wegovy (weight loss), it generated over $20 billion in global sales for Novo Nordisk in 2025. In the US, patients pay $800–$1,350 per month. In India, the same molecule costs $25–$50.

Here is the full pricing, access, and safety picture for international patients.

The Semaglutide Price Gap

The numbers are stark:

Formulation	US Price/Month	India Price/Month	Savings
Ozempic 1mg injection	$900 – $1,100	$30 – $50	~95%
Wegovy 2.4mg injection	$1,300 – $1,350	$40 – $60	~96%
Oral Wegovy (pill)	$900 – $1,100	$35 – $55 (injectable alternative)	~95%
Generic semaglutide (India)	Not available in US	$25 – $45	—

A US patient spending $1,000/month on Ozempic pays $12,000 annually. The same treatment in India costs approximately $300–$600 per year.

Why the Oral Wegovy Launch Matters — And Why India Is Still Cheaper

The FDA approved oral Wegovy in December 2025. Novo Nordisk positioned it as the game-changer: a weight loss pill instead of a weekly injection. But there are critical caveats:

The dosing problem: Oral semaglutide must be taken first thing in the morning on a completely empty stomach with no more than 4 ounces of water. No food, drink, or other medications for 30 minutes. This is because stomach acid and food destroy the peptide molecule — the pill uses a special absorption enhancer (SNAC) that only works under very specific conditions.

The insurance problem: As of May 2026, many US insurers still haven’t added oral Wegovy to their formularies. Patients report denials categorizing it as “experimental” despite full FDA approval.

The India alternative: Indian injectable semaglutide generics — which don’t have the dosing restrictions — remain available at $25–$50/month with no insurance gatekeeping.

Indian Manufacturers: Who Makes What

Company	Semaglutide Product	Regulatory Status	Key Export Markets
Sun Pharma	Injectable semaglutide	CDSCO approved, US FDA facility	150+ countries
Dr. Reddy’s	Injectable semaglutide	CDSCO approved, US FDA facility	100+ countries
USV Limited	Semaglutide injection	CDSCO approved	India, Asia
Cipla	GLP-1 portfolio	Pipeline development	80+ countries
Biocon	GLP-1 biosimilar pipeline	Under development	100+ countries

Sun Pharma and Dr. Reddy’s are the primary suppliers. Both operate manufacturing facilities that have passed US FDA inspection — the same quality standard required for drugs sold in the United States.

Head-to-Head: Semaglutide vs Orforglipron (Foundayo)

With the FDA’s April 2026 approval of Foundayo, patients now face a choice between two oral GLP-1 options in the US. Here is how they compare:

Factor	Oral Wegovy (Semaglutide)	Foundayo (Orforglipron)
Average weight loss	~14%	~11%
Dosing restrictions	Strict (empty stomach, AM only)	Flexible (anytime, with food)
Discontinuation rate	Lower	14x higher
US price	$900 – $1,100/mo	$149 – $349/mo
India generic available	Yes ($25–$50/mo)	Not yet
Molecule type	Peptide	Small molecule

The 14x discontinuation gap is significant. Foundayo is cheaper and more convenient, but more patients stop taking it due to side effects. For cost-conscious patients, Indian generic semaglutide at $25–$50/month undercuts both US options dramatically.

Medical Tourism: The Obesity Treatment Package

Several Indian hospitals now offer structured obesity management programs for international patients:

What a typical 5–7 day package includes:

• Endocrinology consultation — full metabolic assessment, thyroid panel, insulin resistance testing
• Nutritionist consultation — culturally adapted meal planning
• Cardiac risk assessment — ECG, lipid panel, hsCRP
• GLP-1 therapy initiation — dose titration with monitoring
• 3-month medication supply — generic semaglutide at Indian prices
• Telemedicine follow-up — 2-3 remote consultations post-departure

Approximate total package cost:

Component	India	US Equivalent
Full metabolic workup	$150 – $300	$2,000 – $5,000
3-month semaglutide	$75 – $150	$2,700 – $4,050
Specialist consultations (3x)	$60 – $120	$600 – $1,200
Total	$285 – $570	$5,300 – $10,250

Add round-trip flights ($500–$900 to most Indian cities) and the all-in cost is still 85% below the US equivalent.

The Counterfeit Warning

The global demand for semaglutide has created a counterfeit drug market. Critical safety rules:

1. Never buy from unregulated online pharmacies — counterfeit semaglutide has been seized by regulators globally
2. Purchase only from hospital pharmacies or licensed retail chains in India (Apollo Pharmacy, MedPlus, Netmeds)
3. Check batch numbers — legitimate Indian generics have verifiable batch codes on the manufacturer’s website
4. Avoid compounding pharmacies claiming to sell “custom” semaglutide — these are unregulated

Indian hospital pharmacies attached to JCI/NABH-accredited facilities are the safest source. They procure directly from manufacturers and maintain cold-chain integrity for injectable medications.

What’s Next: The Patent Cliff

Novo Nordisk’s core semaglutide patents begin expiring in the late 2020s, with full generic competition expected in the US by 2031-2032. When that happens, US prices will drop — but they’re unlikely to reach Indian levels due to structural differences in the pharmaceutical supply chain.

For patients who need semaglutide now, India offers immediate access at 95% lower cost through established, regulated generic manufacturers.